Therefore, IL-27, similar to IFN-γ may facilitate CTL recognition by HLA-class I antigen presentation [12], and also exerts anti-proliferative effects by directly acting on human tumor cells, including, for example, EOC [12] and multiple myeloma cells [14]. Here, IFNG is linked to neoplasm.